Sobi to refinance existing credit facility
(Thomson Reuters ONE) -
Sobi has decided to refinance its existing credit facility either by issuing a
SEK denominated bond up to SEK 500 M or by entering into a new revolving credit
facility with SEB and Nordea.
The purpose of the refinancing is to improve the financial flexibility and to
extend the maturity profile. The refinancing will replace existing bank debt and
will not increase Sobi's total debt.
Sobi has appointed Nordea as Joint Bookrunner and Co-ordinator together with SEB
as Joint Bookrunner to investigate a bond issue. The lead banks Nordea and SEB
have committed to provide a credit facility in a corresponding amount in the
event that Sobi does not proceed with the bond issue.
For further information, please contact:
Lars Sandström, CFO
Tel.: +46 8 697 26 33
Swedish Orphan Biovitrum (Sobi)
Sobi is a leading integrated biopharmaceutical company dedicated to bringing
innovative therapies and services to improve the health of rare disease patients
and their families. The product portfolio comprises about 45 marketed products
as well as projects in the late clinical phase. Key therapeutic areas are
Inflammation and Genetics & Metabolism. In 2011, Sobi had revenues of SEK 1.9
billion and around 500 employees. The share (STO: SOBI) is listed on NASDAQ OMX
Stockholm. More information is available at www.sobi.com.
The information above has been published pursuant to the Swedish Securities
Market Act and/or the Financial Instruments Trading Act. The information was
released for public distribution on 5 June 2012 at 16.50 CET.
Sobi Press Release on June 5 in pdf format:
http://hugin.info/134557/R/1617484/516151.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Swedish Orphan Biovitrum AB (publ) via Thomson Reuters ONE
[HUG#1617484]
Unternehmensinformation / Kurzprofil:
Datum: 05.06.2012 - 16:53 Uhr
Sprache: Deutsch
News-ID 153399
Anzahl Zeichen: 2454
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 165 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Sobi to refinance existing credit facility"
steht unter der journalistisch-redaktionellen Verantwortung von
Swedish Orphan Biovitrum AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
